Skip to content

Clinical trials

Recruiting Overweight trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Recruiting Country / region: United States Clear all

212 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20162
20181
20191
20203
20214
20228
202315
202428
202550
202699

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting212

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company19
Novo Nordisk A/S17
Johns Hopkins University6
University of Kansas Medical Center6
Hoffmann-La Roche5
Amgen4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
The Miriam Hospital4
University of Utah4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight212
Obesity201
Diabetes Mellitus, Type 227
Weight Loss24
Insulin Resistance13
Diabetes Mellitus10
Hypertension8
Prediabetic State8
Body Weight7
Gestational Weight Gain6

Trials

Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.

112 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.